Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Gastroenterology
|
November 26, 2009
What's causing this woman's chest pain?
Tara Iyengar, Ramesh K Ramanathan, Philip J Gold
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 16, 2010
Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: a phase II Southwest Oncology Group Study (S0415)
Philip J Gold, Bryan Goldman, Syma Iqbal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2013
First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinoma
Andrew X Zhu, Philip J Gold, Anthony B El-Khoueiry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2006
Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer
Neal J Meropol, Philip J Gold, Robert B Diasio, et al.
Cancer Chemotherapy and Pharmacology
|
May 11, 2011
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202
Syma Iqbal, Cathryn Rankin, Heinz-Josef Lenz, et al.
Investigational New Drugs
|
July 13, 2011
SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma
Anthony B El-Khoueiry, Cathryn J Rankin, Edgar Ben-Josef, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 7, 2012
Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414)
Michael B Tomblyn, Bryan H Goldman, Charles R Thomas, et al.
Investigational New Drugs
|
October 23, 2008
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)
Robert P Whitehead, Cathryn Rankin, Paulo M G Hoff, et al.
Cancer Research Communications
|
March 27, 2023
A Phase II Study Investigating Cabozantinib in Patients with Refractory Metastatic Colorectal Cancer (AGICC 17CRC01)
Aaron J Scott, Atrayee Basu Mallick, Efrat Dotan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma
Lawrence P Leichman, Bryan H Goldman, Pierre O Bohanes, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Gastroenterology
|
November 26, 2009
What's causing this woman's chest pain?
Tara Iyengar, Ramesh K Ramanathan, Philip J Gold
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 16, 2010
Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: a phase II Southwest Oncology Group Study (S0415)
Philip J Gold, Bryan Goldman, Syma Iqbal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2013
First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinoma
Andrew X Zhu, Philip J Gold, Anthony B El-Khoueiry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2006
Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer
Neal J Meropol, Philip J Gold, Robert B Diasio, et al.
Cancer Chemotherapy and Pharmacology
|
May 11, 2011
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202
Syma Iqbal, Cathryn Rankin, Heinz-Josef Lenz, et al.
Investigational New Drugs
|
July 13, 2011
SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma
Anthony B El-Khoueiry, Cathryn J Rankin, Edgar Ben-Josef, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 7, 2012
Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414)
Michael B Tomblyn, Bryan H Goldman, Charles R Thomas, et al.
Investigational New Drugs
|
October 23, 2008
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)
Robert P Whitehead, Cathryn Rankin, Paulo M G Hoff, et al.
Cancer Research Communications
|
March 27, 2023
A Phase II Study Investigating Cabozantinib in Patients with Refractory Metastatic Colorectal Cancer (AGICC 17CRC01)
Aaron J Scott, Atrayee Basu Mallick, Efrat Dotan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma
Lawrence P Leichman, Bryan H Goldman, Pierre O Bohanes, et al.
Page
of 3